icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm

Ireland becomes latest nation to halt rollout of AstraZeneca vaccine following new reports of blood clotting

Ireland becomes latest nation to halt rollout of AstraZeneca vaccine following new reports of blood clotting
Ireland has put the brakes on plans to administer the AstraZeneca Covid vaccine, following in the footsteps of other countries that have suspended its use over concerns that the drug may be linked to blood clotting.

The Irish Department of Health confirmed to the media that the rollout of the jab had been “temporarily deferred.” 

The decision came at the urging of Ireland’s National Immunisation Advisory Committee, following four new cases of “serious” blood clotting that occurred in adults who received the vaccine in Norway.

Ireland's deputy chief medical officer, Dr. Ronan Glynn, said shelving the drug was a “precautionary” measure and stressed that there was no established link between the medical issues and the vaccine. 

The European Medicines Agency is currently investigating the issue. AstraZeneca has said that it is conducting its own review and will share any new information “without delay.”

The new advisory comes just two days after Irish medical officials approved the AstraZeneca vaccine for people older than 70. Officials had previously determined that only people under the age of 65 should be given the drug, amid concerns about limited data on its efficacy for older age groups. 

Denmark announced on Thursday that it would suspend use of the AstraZeneca vaccine for two weeks after some recipients of the jab developed blood clots. Norway followed suit, describing the move as a “cautionary decision.”

Austria, Iceland, Italy, and a number of other countries have also postponed or restricted their rollout of the jab after reviewing the worrying reports about potential adverse reactions. 

The World Health Organization has insisted that the vaccine can still be used, as there is no established link between the drug and the blood clotting. 

Like this story? Share it with a friend!

Dear readers and commenters,

We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.

Sorry for the inconvenience, and looking forward to your future comments,

RT Team.

Podcasts